| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Common Stock | Options Exercise | $100K | +1.48K | +8.7% | $67.85* | 18.4K | Aug 3, 2021 | Direct | F1 |
| transaction | IDXX | Common Stock | Options Exercise | $1.26M | +8.87K | +48.1% | $141.60 | 27.3K | Aug 3, 2021 | Direct | |
| transaction | IDXX | Common Stock | Sale | -$4.89M | -7.04K | -25.75% | $695.34 | 20.3K | Aug 3, 2021 | Direct | F2 |
| transaction | IDXX | Common Stock | Sale | -$1.28M | -1.84K | -9.06% | $696.32 | 18.4K | Aug 3, 2021 | Direct | F3 |
| transaction | IDXX | Common Stock | Options Exercise | $916K | +5.14K | +27.87% | $178.26 | 23.6K | Aug 4, 2021 | Direct | |
| transaction | IDXX | Common Stock | Options Exercise | $635K | +3.07K | +13.01% | $206.94 | 26.7K | Aug 4, 2021 | Direct | |
| transaction | IDXX | Common Stock | Options Exercise | $547K | +1.89K | +7.1% | $288.78 | 28.5K | Aug 4, 2021 | Direct | |
| transaction | IDXX | Common Stock | Sale | -$923K | -1.32K | -4.62% | $700.00 | 27.2K | Aug 4, 2021 | Direct | |
| transaction | IDXX | Common Stock | Sale | -$6.47M | -9.24K | -33.94% | $700.30 | 18K | Aug 4, 2021 | Direct | F4 |
| transaction | IDXX | Common Stock | Sale | -$603K | -860 | -4.78% | $701.36 | 17.1K | Aug 4, 2021 | Direct | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Incentive Stock Option (right-to-buy) | Options Exercise | -1.48K | -100% | 0 | Aug 3, 2021 | Common Stock | 1.48K | $67.85 | Direct | F6, F11 | ||
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -8.87K | -85.44% | 1.51K | Aug 3, 2021 | Common Stock | 8.87K | $141.60 | Direct | F7, F11 | ||
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -5.14K | -64.21% | 2.87K | Aug 4, 2021 | Common Stock | 5.14K | $178.26 | Direct | F8, F11 | ||
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -3.07K | -42.69% | 4.12K | Aug 4, 2021 | Common Stock | 3.07K | $206.94 | Direct | F9, F11 | ||
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -1.89K | -25.01% | 5.68K | Aug 4, 2021 | Common Stock | 1.89K | $288.78 | Direct | F10, F11 |
| Id | Content |
|---|---|
| F1 | Includes a total of 21.4780 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021. |
| F2 | Represents the weighted average price of the shares sold ranging from a low of $695.00 to a high of $695.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F3 | Represents the weighted average price of the shares sold ranging from a low of $696.02 to a high of $696.78 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F4 | Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F5 | Represents the weighted average price of the shares sold ranging from a low of $701.05 to a high of $701.91 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F6 | Grant of option to buy 1,476 shares of Issuer common stock that vested as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2020, respectively, and as to the remainder on February 14, 2021. |
| F7 | Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018. |
| F8 | Grant of option to buy 8,007 shares of Issuer common stock that vest in five annual installments beginning February 14, 2019. |
| F9 | Grant of option to buy 7,186 shares of Issuer common stock that vest in four annual installments beginning February 14, 2020. |
| F10 | Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021. |
| F11 | Not applicable. |